Iron in multiple sclerosis: roles in neurodegeneration and repair

[1]  Simon Hametner,et al.  Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Manuel A. Friese,et al.  Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis , 2014, Nature Reviews Neurology.

[3]  H. Lassmann,et al.  Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models , 2014, Acta Neuropathologica.

[4]  A. Suttkus,et al.  Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress , 2014, Cell Death and Disease.

[5]  G. Harauz,et al.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders? , 2014, Cellular and Molecular Life Sciences.

[6]  S. Lynch,et al.  Iron chelation and multiple sclerosis , 2013, ASN neuro.

[7]  R Marc Lebel,et al.  Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. , 2013, Radiology.

[8]  J. Lefaucheur,et al.  Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements , 2013, Neurophysiologie Clinique/Clinical Neurophysiology.

[9]  W. Koppenol,et al.  The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. , 2013, Free radical biology & medicine.

[10]  D. McTigue,et al.  Neonatal E. Coli Infection Causes Neuro-Behavioral Deficits Associated with Hypomyelination and Neuronal Sequestration of Iron , 2013, The Journal of Neuroscience.

[11]  Simon Hametner,et al.  Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.

[12]  V. Yong,et al.  Pathophysiology of the brain extracellular matrix: a new target for remyelination , 2013, Nature Reviews Neuroscience.

[13]  Saifeng Liu,et al.  Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging , 2013, NeuroImage.

[14]  T. Kuhlmann,et al.  Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis. , 2013, The American journal of pathology.

[15]  T. Rouault,et al.  Iron metabolism in the CNS: implications for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[16]  Cris S Constantinescu,et al.  Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome , 2013, Multiple sclerosis.

[17]  J. Dunn,et al.  Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination , 2013, Multiple sclerosis.

[18]  R Marc Lebel,et al.  Multiple sclerosis: validation of MR imaging for quantification and detection of iron. , 2013, Radiology.

[19]  David Pitt,et al.  Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions , 2013, PloS one.

[20]  K. Nakanishi,et al.  A highly-sulfated chondroitin sulfate, CS-E, adsorbs specifically to neurons with nuclear condensation , 2012, Neuroscience Research.

[21]  B. Trapp,et al.  Cortical remyelination: A new target for repair therapies in multiple sclerosis , 2012, Annals of neurology.

[22]  Hans Lassmann,et al.  Progressive multiple sclerosis: pathology and pathogenesis , 2012, Nature Reviews Neurology.

[23]  Scott Sloka,et al.  Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination , 2012, Annals of neurology.

[24]  R. Eisenstein,et al.  Mammalian iron metabolism and its control by iron regulatory proteins. , 2012, Biochimica et biophysica acta.

[25]  T. Arendt,et al.  Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology , 2012, Brain pathology.

[26]  Xavier Golay,et al.  Reduced R2′ in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  A. Bar-Or,et al.  Comparison of polarization properties of human adult microglia and blood‐derived macrophages , 2012, Glia.

[28]  D. McTigue,et al.  Ferritin Stimulates Oligodendrocyte Genesis in the Adult Spinal Cord and Can Be Transferred from Macrophages to NG2 Cells In Vivo , 2012, The Journal of Neuroscience.

[29]  S. David,et al.  Iron Efflux from Astrocytes Plays a Role in Remyelination , 2012, The Journal of Neuroscience.

[30]  R. Marc Lebel,et al.  Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis , 2012, Multiple sclerosis.

[31]  P. Brissot,et al.  Non-transferrin bound iron: a key role in iron overload and iron toxicity. , 2012, Biochimica et biophysica acta.

[32]  M. Núñez,et al.  Iron toxicity in neurodegeneration , 2012, BioMetals.

[33]  Robert Zivadinov,et al.  Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study , 2012, NeuroImage.

[34]  Hellmut Merkle,et al.  Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. , 2012, Radiology.

[35]  A. Suttkus,et al.  Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. , 2012, American journal of neurodegenerative disease.

[36]  Hellmut Merkle,et al.  Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. , 2011, Brain : a journal of neurology.

[37]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[38]  C. Vulpe,et al.  Iron Efflux from Oligodendrocytes Is Differentially Regulated in Gray and White Matter , 2011, The Journal of Neuroscience.

[39]  Massimo Filippi,et al.  7. Mri Assessment of Iron Deposition in Multiple Sclerosis , 2022 .

[40]  Phil Lee,et al.  Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis , 2011, BMC Neuroscience.

[41]  A. Mantovani,et al.  Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. , 2011, Trends in immunology.

[42]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[43]  H. Reichmann,et al.  Iron-dependent functions of mitochondria—relation to neurodegeneration , 2011, Journal of Neural Transmission.

[44]  P. Apostoli,et al.  Polarization dictates iron handling by inflammatory and alternatively activated macrophages , 2010, Haematologica.

[45]  G. Shen.  Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. , 2010, Canadian journal of physiology and pharmacology.

[46]  J. Pasquini,et al.  Oligodendrogenesis: The role of iron , 2010, BioFactors.

[47]  L. Vargova,et al.  Bral1: Its Role in Diffusion Barrier Formation and Conduction Velocity in the CNS , 2010, The Journal of Neuroscience.

[48]  Bejoy Thomas,et al.  Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[49]  E. Englander,et al.  Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA , 2009, Journal of neurochemistry.

[50]  D. McTigue,et al.  Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation , 2009, Experimental Neurology.

[51]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[52]  Elizabeth C. Theil,et al.  Iron-based redox switches in biology. , 2009, Antioxidants & redox signaling.

[53]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[54]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[55]  Yansu Guo,et al.  Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons , 2009, Brain Research.

[56]  M. Mohsenzadegan,et al.  Antioxidant therapy in multiple sclerosis , 2009, Immunopharmacology and immunotoxicology.

[57]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[58]  C. Wiley,et al.  Brain Extracellular Matrix in Neurodegeneration , 2008, Brain pathology.

[59]  P. Riederer,et al.  Iron in neurodegenerative disorders , 2002, Neurotoxicity Research.

[60]  S. Nelson,et al.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.

[61]  D. Kell.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[62]  Hans Lassmann,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[63]  V. Nizet,et al.  Role of the hypoxia inducible factors HIF in iron metabolism , 2008, Cell cycle.

[64]  V. Nizet,et al.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.

[65]  T. Butz,et al.  Intracellular iron concentration of neurons with and without perineuronal nets , 2007 .

[66]  D. Rowitch,et al.  Insulin‐like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination , 2007, Glia.

[67]  Xuesheng Zhang,et al.  Cellular iron status influences the functional relationship between microglia and oligodendrocytes , 2006, Glia.

[68]  T. Rouault,et al.  Brain iron metabolism. , 2006, Seminars in pediatric neurology.

[69]  T. Rouault.  The role of iron regulatory proteins in mammalian iron homeostasis and disease , 2006, Nature chemical biology.

[70]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[71]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[72]  J. Eaton,et al.  Heme, heme oxygenase and ferritin in vascular endothelial cell injury. , 2005, Molecular nutrition & food research.

[73]  C. ffrench-Constant,et al.  Human diseases reveal novel roles for neural laminins , 2005, Trends in Neurosciences.

[74]  L. Fleisher,et al.  Iron alters glutamate secretion by regulating cytosolic aconitase activity. , 2005, American journal of physiology. Cell physiology.

[75]  Klaus-Armin Nave,et al.  High cholesterol level is essential for myelin membrane growth , 2005, Nature Neuroscience.

[76]  S. Schwarz,et al.  Multiple sclerosis and nutrition , 2005, Multiple sclerosis.

[77]  P. Riederer,et al.  Perineuronal nets potentially protect against oxidative stress , 2004, Experimental Neurology.

[78]  R. Sidman,et al.  Integrin-linked kinase is required for laminin-2–induced oligodendrocyte cell spreading and CNS myelination , 2003, The Journal of cell biology.

[79]  Z. Cabantchik,et al.  Labile plasma iron in iron overload: redox activity and susceptibility to chelation. , 2003, Blood.

[80]  J. Connor,et al.  Pre- and Postweaning Iron Deficiency Alters Myelination in Sprague-Dawley Rats , 2003, Developmental Neuroscience.

[81]  J. Beard,et al.  Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.

[82]  J. Eaton,et al.  Haem, haem oxygenase and ferritin in vascular endothelial cell injury. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[83]  T. Moos.  Brain iron homeostasis. , 2002, Danish medical bulletin.

[84]  G. Kress,et al.  The Relationship between Intracellular Free Iron and Cell Injury in Cultured Neurons, Astrocytes, and Oligodendrocytes , 2002, The Journal of Neuroscience.

[85]  T. Taguchi,et al.  Histochemical study of perineuronal nets in the retrosplenial cortex of adult rats. , 2002, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[86]  J. Eaton,et al.  Molecular bases of cellular iron toxicity. , 2002, Free radical biology & medicine.

[87]  R. Sobel,et al.  White Matter Extracellular Matrix Chondroitin Sulfate/Dermatan Sulfate Proteoglycans in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[88]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[89]  D. Chaplin,et al.  Interleukin-1β Promotes Repair of the CNS , 2001, The Journal of Neuroscience.

[90]  D. Morath,et al.  Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes. , 2001, Developmental biology.

[91]  W. Willett,et al.  Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women , 2001, Neurology.

[92]  F. Torti,et al.  Ferritin and the response to oxidative stress. , 2001, Biochemical Journal.

[93]  F. Petrat,et al.  Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. , 2001, The Biochemical journal.

[94]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[95]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[96]  S. Lynch,et al.  A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. , 2000, Cellular and molecular biology.

[97]  G. Semenza.  HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.

[98]  I. Fridovich.  Fundamental Aspects of Reactive Oxygen Species, or What's the Matter with Oxygen? , 1999, Annals of the New York Academy of Sciences.

[99]  M. Asanuma,et al.  Glial Cells Protect Neurons Against Oxidative Stress via Transcriptional Up‐Regulation of the Glutathione Synthesis , 1999, Journal of neurochemistry.

[100]  S. LeVine,et al.  Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.

[101]  L. Que,et al.  Oxygen activating nonheme iron enzymes. , 1998, Current opinion in chemical biology.

[102]  B. Juurlink.  Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and Glutathione , 1997, Neuroscience & Biobehavioral Reviews.

[103]  R. Miledi,et al.  Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[104]  B. Van Houten,et al.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Lynch,et al.  Desferrioxamine in chronic progressive Multiple Sclerosis: a pilot study , 1996, Multiple sclerosis.

[106]  B. Juurlink,et al.  Low Glutathione and High Iron Govern the Susceptibility of Oligodendroglial Precursors to Oxidative Stress , 1996, Journal of neurochemistry.

[107]  J. Connor,et al.  Relationship of iron to oligodendrocytes and myelination. , 1996, Glia.

[108]  C. Palmer,et al.  A histochemical study of iron‐positive cells in the developing rat brain , 1995, The Journal of comparative neurology.

[109]  M. Nedergaard,et al.  Vitamin E, Ascorbate, Glutathione, Glutathicne Disulfide, and Enzymes of Glutathione Metabolism in Cultures of Chick Astrocytes and Neurons: Evidence that Astrocytes Play an Important Role in Antioxidative Processes in the Brain , 1994, Journal of neurochemistry.

[110]  J. Connor,et al.  Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain , 1993, The Journal of comparative neurology.

[111]  P. Riederer,et al.  The possible role of iron in the etiopathology of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[112]  J. Connor,et al.  Iron regulation in the brain: Histochemical, biochemical, and molecular considerations , 1992, Annals of neurology.

[113]  W. Savino,et al.  Influence of iron-deficiency anemia on selected thymus functions in mice: thymulin biological activity, T-cell subsets, and thymocyte proliferation. , 1990, The American journal of clinical nutrition.

[114]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[115]  J. Brock,et al.  Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator. , 1987, Immunology letters.

[116]  B. Halliwell,et al.  The importance of free radicals and catalytic metal ions in human diseases. , 1985, Molecular aspects of medicine.

[117]  W. Cammer.  Oligodendrocyte-Associated Enzymes , 1984 .

[118]  P. Reichard,et al.  Ribonucleotide reductase--a radical enzyme. , 1983, Science.

[119]  S. Fahn,et al.  Muscle Disorders in Childhood , 1979, Neurology.

[120]  D. Pleasure,et al.  Enzyme markers for myelination of mouse cerebellum in vivo and in tissue culture , 1976, Brain Research.